Highlights TherapeuticsMD, Inc.

Equities

TXMD

US88338N2062

Delayed Nasdaq Other stock markets 02:00:08 2024-04-29 pm EDT			5-day change	1st Jan Change
1.895 ^USD	+1.87%		+0.79%	-15.79%

Mar. 29	TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 06	Knight Therapeutics Announces Launch of Bijuva in Canada	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Knight Therapeutics Announces Launch of Bijuva in Canada	Feb. 06	MT
Knight Therapeutics Announces Product Launch For IMVEXXY In Canada	Jan. 04	MT
TherapeuticsMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
TherapeuticsMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
TherapeuticsMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-07	CI
TherapeuticsMD Completes Product License Deal to Mayne Pharma Group	23-01-03	MT
Mayne Pharma Group Completes Exclusive Product Licensing Deal	23-01-02	MT
Mayne Pharma Group Limited Completes TherapeuticsMD, Inc. Product Licensing Transaction	23-01-02	CI
Mayne Pharma, Inc. completed the acquisition of Certain Assets of TherapeuticsMD, Inc.	22-12-29	CI
Services Data and Factory Orders Anticipation Drag Exchange-Traded Funds, Stock Futures Lower	22-12-05	MT
TherapeuticsMD Agrees to Grant Product License to Mayne Pharma Group; Shares Surge Pre-Bell	22-12-05	MT
Mayne Pharma Group Signs Exclusive License Deal for Women's Health Products, Prenatal Vitamins; Shares Slump 13%	22-12-04	MT
TherapeuticsMD, Inc. Enter into Definitive Agreements to License its Products to an Affiliate of Mayne Pharma Group Limited for Commercialization in the United States	22-12-04	CI
Mayne Pharma Group Limited agreed to acquire Certain Assets of TherapeuticsMD, Inc..	22-12-03	CI
TherapeuticsMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Earnings Flash (TXMD) THERAPEUTICSMD Reports Q3 Revenue $20.9M	22-11-14	MT
TherapeuticsMD Swings to Q2 Profit as Revenue Rises; Shares Gain	22-08-15	MT
Earnings Flash (TXMD) THERAPEUTICSMD Posts Q2 Revenue $28.6M, vs. Street Est of $23.2M	22-08-15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights TherapeuticsMD, Inc.

Equities

TXMD

US88338N2062

Highlights

Filters